Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.93 USD | +8.79% | +11.24% | +31.50% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 543M | Sales 2025 * | 575M | Capitalization | 407M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 8M | EV / Sales 2024 * | 1.35 x |
Net Debt 2024 * | 328M | Net Debt 2025 * | 276M | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
-85.9
x | P/E ratio 2025 * |
95.4
x | Employees | 995 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.13% |
Latest transcript on Bioventus Inc.
1 day | +8.79% | ||
1 week | +11.24% | ||
Current month | +75.00% | ||
1 month | +74.12% | ||
3 months | +40.57% | ||
6 months | +71.96% | ||
Current year | +31.50% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Claypoole
CEO | Chief Executive Officer | 52 | Jan. 09 |
Mark Singleton
DFI | Director of Finance/CFO | 55 | 22-03-20 |
Katrina Church
CMP | Compliance Officer | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
CHM | Chairman | 70 | 16-06-29 |
Guy Nohra
BRD | Director/Board Member | 63 | 19-12-31 |
Martin Sutter
BRD | Director/Board Member | 69 | 16-06-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +10.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 6.93 | +8.79% | 742,094 |
24-05-24 | 6.37 | +0.63% | 238,478 |
24-05-23 | 6.33 | +0.48% | 354,462 |
24-05-22 | 6.3 | +2.27% | 210,722 |
24-05-21 | 6.16 | -1.12% | 154,123 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.50% | 407M | |
+75.56% | 12.55B | |
-23.35% | 7.51B | |
+8.51% | 6.74B | |
+14.95% | 5.48B | |
-14.65% | 4.93B | |
+30.59% | 4.71B | |
-24.40% | 3.83B | |
-22.61% | 2.9B | |
+49.50% | 2.49B |
- Stock Market
- Equities
- BVS Stock